Main text
Over the years, it has become clear to all stakeholders—scientists, clinicians, industry professionals, and policymakers—that scientific discovery and medical innovation are only possible through a synergistic blend of passion, expertise, and collaboration, leading to transformative breakthroughs. As I step into the role of Editor-in-Chief for Molecular Therapy Methods and Clinical Development, this understanding deeply informs my approach and vision for the journal. This role offers me a unique vantage point to influence the dynamic and ever-evolving field of gene and cell therapy—a field that not only represents the cutting edge of biomedical research but also holds the keys to unlocking treatments for some of the most intractable diseases facing humanity today.
Our journal, a proud member of the American Society for Gene and Cell Therapy (ASGCT) family of publications, has always been at the forefront of publishing groundbreaking research that bridges the gap between innovative laboratory techniques and clinical application. The journal has carved out a niche for itself as a leading platform for disseminating transformative research that advances the broad array of fields under the Molecular Therapy umbrella.
Throughout my career, I have had the privilege to engage in various stages of cell therapy translation, from basic science to manufacturing, clinical trial design and conduct, to regulatory science and economic evaluations. This diverse experience has afforded me a comprehensive understanding of the complexities involved in the process and the challenges that often arise. It’s given me a keen insight into the pain points and the types of research necessary to advance the field. As a physician-scientist, I also place immense value on incorporating the patient’s voice into our work, recognizing that their insights and experiences are invaluable in shaping the direction and focus of our research. As such, we are committed to championing patient-centered research that advances the science of gene and cell therapy while ensuring these advancements are accessible and beneficial to all segments of society. To this end, the voices of patients, the perspectives of underrepresented researchers, the insights from diverse communities, and the contributions of policymakers are not just welcomed—they are critical to driving meaningful progress in our field.
Therefore, my vision for the journal is both expansive and inclusive. I strongly believe that the future of healthcare, particularly in the areas we cover, is incredibly bright and brimming with potential. However, realizing this potential is not a task for lone individuals. I aim to continue the collective efforts of our society, previous editors, and the great team of scientists that have been involved in this journal, to foster a vibrant community where everyone comes together to share their discoveries, insights, and methodologies. Our mission is to facilitate a dialogue that propels the field forward and fosters a collaborative environment conducive to innovation. This vision is shared by all of our editorial team and ASGCT leadership.
As an open access journal, your work will be immediately and freely available to the global scientific community, ensuring maximum visibility and impact. Our commitment to maintaining the highest standards of peer review means that your work will be rigorously evaluated and honed to become its best version, which in turn, enhances the work’s credibility and reach. We understand the importance of timely dissemination of research findings. Thus, among our priorities is to streamline the submission and review process to get your work published as quickly as possible. Our focus is on publishing research that bridges the gap from lab discoveries to clinical practice, establishing ourselves as a key platform for gene and cell therapy advancements poised for patient application. We take pride in our diverse coverage of topics that fall within the translational continuum of gene and cell therapy.
I extend a personal invitation to all those at the frontier of gene and cell therapy research. Whether your work explores novel therapeutic approaches, navigates the path of bringing laboratory discoveries to clinical trials, or pioneers new methodologies for tackling old problems, we want to be the home for your research. Your work has the potential to set the course for future therapies, transforming how we treat, manage, and ultimately cure diseases.
I am both humbled and exhilarated by the journey that lies ahead. The path we are on is not without its challenges, but the potential rewards for humanity are unparalleled. I am excited to embark on this journey with you, our community, readers, and contributors. Together, we can accelerate the pace of innovation in gene and cell therapy, turning today’s scientific inquiries into tomorrow’s medical solutions.